Case 4 In A Media Interview A Famous Microbiologist Suggested The Covid 19 Will Most Probably Attenuate To Become A Fl 1 (82.81 KiB) Viewed 32 times
Case 4 In A Media Interview A Famous Microbiologist Suggested The Covid 19 Will Most Probably Attenuate To Become A Fl 2 (12.7 KiB) Viewed 32 times
Case 4 In A Media Interview A Famous Microbiologist Suggested The Covid 19 Will Most Probably Attenuate To Become A Fl 3 (15.83 KiB) Viewed 32 times
Case 4: In a media interview, a famous microbiologist suggested the COVID-19 will most probably attenuate to become a flu-like disease in the coming future, but it will never leave us. He predicts this pandemic will be ended within one to two years. He raised the adapted human coronaviruses such as 229E and OC43 as examples to support his hypothesis. Q16. Why does this microbiologist have such a prediction? A. The Omicron variant was found to increase both infectivity and pathogenicity. B. The Omicron variant was found to decrease both infectivity and pathogenicity. C. The Omicron variant was found to increase in infectivity but decrease in pathogenicity. D. The Omicron variant was found to decrease in infectivity but increase in pathogenicity. Q17. Which of the following is the most susceptible period for human beings to develop severe disease from a viral infection? A. When the virus just jumps from wild animal to human. B. When the virus spreads in human beings for many generations and gains multiple mutations. C. When the virus adapts to our immune system. D. When the virus is capable to transmit from human to wild animal. Q18. Which of the following is a possible strategy to end the pandemic of COVID-19? A. Develop an effective vaccine and the majority of the world's populations are being vaccinated. B. Develop an effective drug against the SARS-CoV-2 infection. C. Develop herd immunity in the world and eliminate the transmission route of SARS-CoV-2 in human beings. D. All of the above.
Q19. Which of the following protein mutations from the SARS-CoV-2 we are most concerned about? A. RNA-dependent RNA polymerase B. Protease C. Spike (S) protein D. Nucleocapsid (N) protein
Q20. Including those in the clinical trial, which of the following drugs is the most desirable agent that should be safe and effective in treating different stages of COVID-19 patients? A. Remdesivir B. Neutralizing antibodies C. Molnupiravir D. Paxlovid
Join a community of subject matter experts. Register for FREE to view solutions, replies, and use search function. Request answer by replying!